Physiologically based pharmacokinetics (PBPK)
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical species, and many different approaches have been proposed over the years to improve its predictive performance. Nevertheless, prediction errors are commonly observed in the practical application of simple allometry, for example, in cases where the hepatic metabolic clearance is mainly determined by enzyme activities, which do not scale allometrically across species. Therefore, if good correlation was noted for some drugs, poor correlation was observed for others, highlighting the need for other conceptual approaches. Physiologically based pharmacokinetic (PBPK) models are now a well-established approach to conduct extrapolations across species and to generate simulations of pharmacokinetic profiles under various physiological conditions. While conventional pharmacokinetic models are defined by drug-related data themselves, PBPK models have richer information content and integrate information from various sources, including drug-dependent, physiological, and biological parameters as they vary in between species, subjects, or with age and disease state. Therefore, the biological and mechanistic bases of PBPK models allow the extrapolation of the kinetic behavior of drugs with regard to dose, route, and species. In addition, by providing a link between tissue concentrations and toxicological or pharmacological effects, PBPK modeling represents a framework for mechanistic pharmacokinetic-pharmacodynamic models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925 · cited 1×
“This example aims to illustrate how to integrate in vitro metabolism data into physiological models to predict in vivo kinetic profiles (Houston, 1994; De Buck and Mackie, 2007c).”
BackgroundRodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776 · cited 4×
“All physiological data on f EW , f IW , f NL , f NP , and [AP] T for both adipose and nonadipose tissue have been described in the literature (Rodgers et al., 2005), pKa represents the dissociation constant of the protonated base, and P is the anti-log value of log P vo:w (calculated from P oc:w…”
BackgroundInfluentialPredicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
Boxenbaum, H. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062336 · Cited by 648 · cited 8×
“This rule provides selection criteria for the use of MLP or BrW, based on the values of the exponents obtained from simple allometry (Mahmood and Balian, 1996b).”
BackgroundMethodInfluentialPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568
The Simcyp ® Population-based ADME Simulator
Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802691074 · Cited by 533
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530 · cited 3×
“, 2006), and in the evaluation of age-related changes in pediatrics (Björkman, 2004; Johnson et al., 2006).”
BackgroundMethodMechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420 · cited 1×
“Using this tissue composition-based approach, Rodgers and Rowland where also able to derive equations to predict the tissue distribution (Kps) of acids, very weak bases, neutrals, and zwitterions (Rodgers and Rowland, 2006, 2007).”
MethodDedrick, R. L. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059667 · Cited by 397 · cited 1×
“The empirical allometric scaling of pharmacokinetic parameters is based on Equation 1, assuming that there are anatomical, physiological, and biochemical similarities among animals (Dedrick, 1973; Mordenti, 1986).”
Background
Cited by
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
In Vivo Biodistribution of Nanoparticles
Almeida, J. P. M., Chen, A. L., Foster, A., & Drezek, R. (2011) · Nanomedicine · doi:10.2217/nnm.11.79 · Cited by 583
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00726 · Cited by 446
Eissing, T. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00004 · Cited by 204
Hall, C., Lueshen, E., Mošat', A., & Linninger, A. A. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22811 · Cited by 109
Metadata
- Authors
- Espié, P., Tytgat, D., Sargentini-Maier, M.-L., Poggesi, I., & Watelet, J.-B.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2009-07-15
- Volume
- 41
- Issue
- 3
- Pages
- 391-407
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2137752893
- Cited by
- 136
- References
- 28
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physiologically based pharmacokinetics (PBPK). https://app.cochat.ai/papers/10.1080/10837450902891360
- The paper
- Espié, P., Tytgat, D., Sargentini-Maier, M.-L., Poggesi, I., & Watelet, J.-B. (2009). Physiologically based pharmacokinetics (PBPK). Drug Metabolism Reviews. https://doi.org/10.1080/10837450902891360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.